Nu Skin Enterprises Files 8-K on Financials
Ticker: NUS · Form: 8-K · Filed: Aug 8, 2024 · CIK: 1021561
| Field | Detail |
|---|---|
| Company | Nu Skin Enterprises, Inc. (NUS) |
| Form Type | 8-K |
| Filed Date | Aug 8, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, operations
Related Tickers: NUS
TL;DR
NU SKIN dropped an 8-K on Aug 8th detailing financial results - check the exhibits for the real numbers.
AI Summary
Nu Skin Enterprises, Inc. filed an 8-K on August 8, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits related to the company's performance. Specific financial figures and operational details are expected to be found within the attached documents.
Why It Matters
This filing provides investors with crucial updates on Nu Skin Enterprises' financial health and operational performance, impacting investment decisions.
Risk Assessment
Risk Level: medium — 8-K filings often contain material information that can significantly impact a company's stock price, requiring careful analysis.
Key Players & Entities
- NU SKIN ENTERPRISES, INC. (company) — Registrant
- August 8, 2024 (date) — Filing Date
- Delaware (jurisdiction) — State of Incorporation
- 75 West Center Street Provo, Utah 84601 (address) — Principal Executive Offices
- GREGORY BELLISTON (person) — Contact Person
FAQ
What specific financial results are being reported in this 8-K?
The 8-K filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', but the specific figures are detailed within the attached documents.
When was this 8-K filing submitted to the SEC?
The filing was submitted on August 8, 2024.
What is Nu Skin Enterprises, Inc.'s primary business classification?
Nu Skin Enterprises, Inc. is classified under Standard Industrial Classification code 5122: Wholesale - Drugs, Proprietaries & Druggists' Sundries.
Where are Nu Skin Enterprises, Inc.'s principal executive offices located?
The principal executive offices are located at 75 West Center Street, Provo, Utah 84601.
What is the Commission File Number for Nu Skin Enterprises, Inc.?
The Commission File Number for Nu Skin Enterprises, Inc. is 001-12421.
Filing Stats: 520 words · 2 min read · ~2 pages · Grade level 10.3 · Accepted 2024-08-08 16:15:40
Filing Documents
- ef20033803_8k.htm (8-K) — 29KB
- ef20033803_ex99-1.htm (EX-99.1) — 561KB
- image00001.jpg (GRAPHIC) — 4KB
- 0001140361-24-036406.txt ( ) — 758KB
- nus-20240808.xsd (EX-101.SCH) — 4KB
- nus-20240808_lab.xml (EX-101.LAB) — 21KB
- nus-20240808_pre.xml (EX-101.PRE) — 16KB
- ef20033803_8k_htm.xml (XML) — 4KB
02
Item 2.02 Results of Operations and Financial Condition. On August 8, 2024, Nu Skin Enterprises, Inc. (the "Company") issued a press release announcing its financial results for the three- and six-month periods ended June 30, 2024, and certain other information. A copy of the press release is attached as Exhibit 99.1 to this report. The information furnished pursuant to this Item 2.02 and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. 99.1 Nu Skin Enterprises' press release dated August 8, 2024, regarding financial results for the three- and six-month periods ended June 30, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NU SKIN ENTERPRISES, INC. (Registrant) /s/ James D. Thomas James D. Thomas Chief Financial Officer Date: August 8, 2024